These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26292758)

  • 1. Principles of antibody-mediated TNF receptor activation.
    Wajant H
    Cell Death Differ; 2015 Nov; 22(11):1727-41. PubMed ID: 26292758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF).
    Medler J; Wajant H
    Methods Mol Biol; 2021; 2248():81-90. PubMed ID: 33185869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity.
    Medler J; Nelke J; Weisenberger D; Steinfatt T; Rothaug M; Berr S; Hünig T; Beilhack A; Wajant H
    Cell Death Dis; 2019 Mar; 10(3):224. PubMed ID: 30833543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily.
    Zaitseva O; Anany M; Wajant H; Lang I
    Front Immunol; 2023; 14():1115667. PubMed ID: 37051245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.
    Lang I; Füllsack S; Wyzgol A; Fick A; Trebing J; Arana JA; Schäfer V; Weisenberger D; Wajant H
    J Biol Chem; 2016 Mar; 291(10):5022-37. PubMed ID: 26721880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking.
    Liu L; Wu Y; Ye K; Cai M; Zhuang G; Wang J
    Front Pharmacol; 2022; 13():924197. PubMed ID: 35865955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism.
    Aido A; Zaitseva O; Wajant H; Buzgo M; Simaite A
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.
    Wyzgol A; Müller N; Fick A; Munkel S; Grigoleit GU; Pfizenmaier K; Wajant H
    J Immunol; 2009 Aug; 183(3):1851-61. PubMed ID: 19596991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction.
    Huet HA; Growney JD; Johnson JA; Li J; Bilic S; Ostrom L; Zafari M; Kowal C; Yang G; Royo A; Jensen M; Dombrecht B; Meerschaert KR; Kolkman JA; Cromie KD; Mosher R; Gao H; Schuller A; Isaacs R; Sellers WR; Ettenberg SA
    MAbs; 2014; 6(6):1560-70. PubMed ID: 25484045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.
    Dostert C; Grusdat M; Letellier E; Brenner D
    Physiol Rev; 2019 Jan; 99(1):115-160. PubMed ID: 30354964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Necrosis Factor Receptor Superfamily in T Cell Priming and Effector Function.
    Muller J; Baeyens A; Dustin ML
    Adv Immunol; 2018; 140():21-57. PubMed ID: 30366518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Development of a Protein-Protein Interaction Inhibitor Targeting Tumor Necrosis Factor Receptor-Associated Factor 6.
    Moriya J; Takeuchi K; Tai K; Arai K; Kobayashi N; Yoneda N; Fukunishi Y; Inoue A; Kihara M; Murakami T; Chiba K; Shimada I
    J Med Chem; 2015 Jul; 58(14):5674-83. PubMed ID: 26132273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.
    Silke J; Brink R
    Cell Death Differ; 2010 Jan; 17(1):35-45. PubMed ID: 19680262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily.
    Kucka K; Wajant H
    Front Cell Dev Biol; 2020; 8():615141. PubMed ID: 33644033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A co-evolution perspective of the TNFSF and TNFRSF families in the immune system.
    Collette Y; Gilles A; Pontarotti P; Olive D
    Trends Immunol; 2003 Jul; 24(7):387-94. PubMed ID: 12860530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational analyses of the interactome between TNF and TNFR superfamilies.
    Dhusia K; Su Z; Wu Y
    Comput Biol Chem; 2023 Apr; 103():107823. PubMed ID: 36682326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.
    He Y; Vlaming M; van Meerten T; Bremer E
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
    Spanjaard RA; Whren KM; Graves C; Bhawan J
    Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.
    Twohig JP; Cuff SM; Yong AA; Wang EC
    Rev Neurosci; 2011; 22(5):509-33. PubMed ID: 21861782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.